| Rospotrebnadzor (Russia’s consumer health watchdog) | SanPiN 3.3686-21 “Sanitary and epidemiological requirements for the prevention of infectious diseases” (Russian sanitary rules, in force until September 1, 2027) (in Russian) | 1 · Russian regulatory document | October 7, 2026 |
| Russian Ministry of Health | Clinical guidelines “Acute respiratory viral infections (ARVI) in adults”, ID 724_2, published in the guidelines database on August 4, 2025 (in Russian) | 1 · Russian regulatory document | October 9, 2026 |
| Russian Ministry of Health | Clinical guidelines “Pneumonia (community-acquired)”, children, ID 714_2, published in the guidelines database on September 8, 2025 (in Russian) | 1 · Russian regulatory document | October 10, 2026 |
| Russian Ministry of Health | Clinical guidelines “Community-acquired pneumonia in adults”, ID 654_2, published in the guidelines database on December 23, 2024 (in Russian) | 1 · Russian regulatory document | October 10, 2026 |
| Russian Ministry of Health | Clinical guidelines “Acute bronchiolitis”, children, ID 360_3, published in the guidelines database on January 14, 2025 (in Russian) | 1 · Russian regulatory document | October 10, 2026 |
| Russian Ministry of Health | Clinical guidelines “Rotavirus gastroenteritis in children”, ID 755_1, published in the guidelines database on March 3, 2023 (in Russian) | 1 · Russian regulatory document | October 12, 2026 |
| Russian Ministry of Health | Clinical guidelines “Norovirus gastroenteritis in children”, ID 825_1, published in the guidelines database on November 26, 2024 (in Russian) | 1 · Russian regulatory document | October 12, 2026 |
| Russian Ministry of Health | Information notice of August 11, 2020 on the registration of the Gam-COVID-Vac vaccine (registration certificate LP-006395), copy in ConsultantPlus (in Russian) | 1 · Russian regulatory document | October 12, 2026 |
| Russian Ministry of Health, Association of Ophthalmologists, Russian Ophthalmological Society | Clinical guidelines “Conjunctivitis”, adults and children, ID 629_2, 2024 (in Russian) | 1 · Russian regulatory document | October 8, 2026 |
| Russian Ministry of Health, Union of Pediatricians of Russia | Clinical guidelines “Acute respiratory viral infection (ARVI)”, children, ID 25_3, published in the guidelines database on September 2, 2026 (in Russian) | 1 · Russian regulatory document | October 8, 2026 |
| Gamaleya National Research Center for Epidemiology and Microbiology | Logunov D. Yu. 40 years of developing vector platforms. Talk at the Bakh Readings, 2024 (in Russian) | 2 · Russian research institute or government agency | October 12, 2026 |
| CDC (US Centers for Disease Control and Prevention) | About Adenovirus | 3 · International health organization | October 7, 2026 |
| CDC (US Centers for Disease Control and Prevention) | Clinical Overview of Adenovirus | 3 · International health organization | October 7, 2026 |
| CDC (US Centers for Disease Control and Prevention) | About Pink Eye (Conjunctivitis) | 3 · International health organization | October 8, 2026 |
| CDC (US Centers for Disease Control and Prevention) | Similarities and Differences between Flu and COVID-19 | 3 · International health organization | October 9, 2026 |
| CDC (US Centers for Disease Control and Prevention) | Preventing Epidemic Keratoconjunctivitis (EKC) in Healthcare Settings | 3 · International health organization | October 10, 2026 |
| CDC (US Centers for Disease Control and Prevention) | About Rotavirus | 3 · International health organization | October 12, 2026 |
| CDC (US Centers for Disease Control and Prevention) | About Norovirus | 3 · International health organization | October 12, 2026 |
| CDC (US Centers for Disease Control and Prevention) | How to Prevent Norovirus | 3 · International health organization | October 12, 2026 |
| CDC (US Centers for Disease Control and Prevention) | About Human Parainfluenza Viruses | 3 · International health organization | October 12, 2026 |
| CDC (US Centers for Disease Control and Prevention) | About RSV | 3 · International health organization | October 12, 2026 |
| CDC (US Centers for Disease Control and Prevention) | RSV: Symptoms and Care | 3 · International health organization | October 12, 2026 |
| CDC (US Centers for Disease Control and Prevention) | About Common Cold | 3 · International health organization | October 12, 2026 |
| CDC (US Centers for Disease Control and Prevention) | About Non-Polio Enteroviruses | 3 · International health organization | October 12, 2026 |
| CDC (US Centers for Disease Control and Prevention) | Signs and Symptoms of Flu | 3 · International health organization | October 12, 2026 |
| CDC (US Centers for Disease Control and Prevention) | How Viral Vector COVID-19 Vaccines Work (fact sheet) | 3 · International health organization | October 12, 2026 |
| CDC, MMWR | Human Adenovirus Surveillance — United States, 2003–2016 | 3 · International health organization | October 7, 2026 |
| CDC, MMWR | Adenovirus-Associated Epidemic Keratoconjunctivitis Outbreaks — Four States, 2008–2010. MMWR 2013;62(32):637–641 | 3 · International health organization | October 8, 2026 |
| CDC, MMWR | Acute Respiratory Disease Associated with Adenovirus Serotype 14 — Four States, 2006–2007. MMWR 2007;56(45):1181–1184 | 3 · International health organization | October 10, 2026 |
| EMA (European Medicines Agency) | Vaxzevria (previously COVID-19 Vaccine AstraZeneca): EPAR | 3 · International health organization | October 12, 2026 |
| EMA (European Medicines Agency) | Vaxzevria: overview (EPAR medicine overview) | 3 · International health organization | October 12, 2026 |
| EMA (European Medicines Agency) | AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets, April 7, 2021 | 3 · International health organization | October 12, 2026 |
| EMA (European Medicines Agency) | Zabdeno: EPAR | 3 · International health organization | October 12, 2026 |
| FDA (US Food and Drug Administration) | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral — Prescribing Information (Initial U.S. Approval: 2011, revised 10/2019) | 3 · International health organization | October 10, 2026 |
| FDA (US Food and Drug Administration) | Janssen COVID-19 Vaccine | 3 · International health organization | October 12, 2026 |
| FDA (US Food and Drug Administration) | Adstiladrin (nadofaragene firadenovec-vncg) | 3 · International health organization | October 12, 2026 |
| WHO (World Health Organization) | International Classification of Diseases, 10th Revision (ICD-10), code J12.0 “Adenoviral pneumonia” | 3 · International health organization | October 10, 2026 |
| WHO (World Health Organization) | Prequalification: COVID-19 Vaccine (Ad5-nCoV-S [Recombinant]) — Convidecia | 3 · International health organization | October 12, 2026 |
| Human Adenovirus Working Group | Registry of human adenovirus types | 4 · Scientific classification | October 7, 2026 |
| ICTV (International Committee on Taxonomy of Viruses) | ICTV Virus Taxonomy Profile: Adenoviridae 2022. J Gen Virol 103(3) | 4 · Scientific classification | October 7, 2026 |
| ICTV (International Committee on Taxonomy of Viruses) | ICTV Report: Family Adenoviridae (Benkő M. et al., updated 2026) | 4 · Scientific classification | October 10, 2026 |
| Acta Naturae | Bagaev A. V., …, Logunov D. Yu., Naroditsky B. S., Gintsburg A. L. Regulation of the target protein (transgene) expression in the adenovirus vector DNA using Toll-like receptor agonists. 2014;6(4) (in Russian) | 5 · Peer-reviewed study | October 12, 2026 |
| BMC Infectious Diseases | Khales P. et al. Human adenoviruses in children with gastroenteritis: a systematic review and meta-analysis. BMC Infect Dis. 2024 | 5 · Peer-reviewed study | October 9, 2026 |
| Bulletin of Altai State Agrarian University | Nikonenko T. B., Meltsov I. V., Baryshnikov P. I. Associated viral infections of dogs in the city of Irkutsk. 2017;8(154):165–170 (in Russian) | 5 · Peer-reviewed study | October 10, 2026 |
| Emerging Microbes & Infections | Borkenhagen L. K. et al. Are adenoviruses zoonotic? A systematic review of the evidence. 2019;8:1679–1687 | 5 · Peer-reviewed study | October 10, 2026 |
| Frontiers in Cellular and Infection Microbiology | Zhu Y. et al. Difference Analysis Between Canine Adenovirus Types 1 And 2. 2022;12:854876 | 5 · Peer-reviewed study | October 10, 2026 |
| Journal of Medical Ethics | Savulescu J. Harm, ethics committees and the gene therapy death. 2001;27(3):148–150 | 5 · Peer-reviewed study | October 12, 2026 |
| Nature Biotechnology | Pearson S., Jia H., Kandachi K. China approves first gene therapy. 2004;22(1):3–4 | 5 · Peer-reviewed study | October 12, 2026 |
| Pediatrics | Kotloff K. L. et al. Enteric adenovirus infection and childhood diarrhea: an epidemiologic study in three clinical settings. Pediatrics. 1989;84(2):219–225 | 5 · Peer-reviewed study | October 12, 2026 |
| The Lancet | Logunov D. Y. et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397:671–681 | 5 · Peer-reviewed study | October 10, 2026 |
| The Lancet Regional Health – Europe | Tukhvatulin A. I. et al. An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults. 2021;11:100241 | 5 · Peer-reviewed study | October 12, 2026 |
| WSAVA (World Small Animal Veterinary Association) | Squires R. A. et al. 2024 guidelines for the vaccination of dogs and cats. J Small Anim Pract. 2024;65(5):277–316 — summary and official translation on the WSAVA website | 5 · Peer-reviewed study | October 10, 2026 |
| npj Vaccines | Mendonça S. A. et al. Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic. 2021;6:97 | 5 · Peer-reviewed study | October 12, 2026 |
| npj Vaccines | Travieso T. et al. The use of viral vectors in vaccine development. 2022;7:75 | 5 · Peer-reviewed study | October 12, 2026 |
| Drugs.com (FDA-approved prescribing information) | Adstiladrin (nadofaragene firadenovec-vncg): Prescribing Information | 6 · Professional medical or veterinary reference | October 12, 2026 |
| MSD Manual Professional Version | Katz S. Adenovirus Infections (fully revised July 2026) | 6 · Professional medical or veterinary reference | October 10, 2026 |
| Merck Veterinary Manual | Creevy K. E., Evans J. B. Infectious Canine Hepatitis (updated June 2026) | 6 · Professional medical or veterinary reference | October 10, 2026 |
| Merck Veterinary Manual | Tonozzi C. C. Kennel Cough (Canine Infectious Tracheobronchitis) (updated September 2024) | 6 · Professional medical or veterinary reference | October 10, 2026 |
| Russian Drug Register (RLS) | GamEvac-Combi: combined vector vaccine against Ebola virus disease, LP-003390 (in Russian) | 6 · Professional medical or veterinary reference | October 12, 2026 |
| Today’s Veterinary Practice (NAVC journal) | Burling A. Canine Adenovirus Type 2 Vaccination, 2021 | 6 · Professional medical or veterinary reference | October 10, 2026 |
| Vidal veterinary drug reference (based on the Russian State Register) | Multikan-4: vaccine against canine distemper, adenovirus infections, and parvovirus and coronavirus enteritis in dogs (in Russian) | 6 · Professional medical or veterinary reference | October 10, 2026 |